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Abstract
Background: Bile leak after liver transplantation (LT) is commonly treated with endoscopic retrograde cholangiopancreato-
graphy (ERCP); however, there are limited data regarding the optimal treatment strategy.
Objective: We aimed to examine the role of ERCP in LT recipients with bile leaks at two large institutions.
Methods: We reviewed all ERCPs performed in LT recipients with bile leak and duct-to-duct biliary anastomosis at two
high-volume transplant centers.
Results: Eighty patients were included. Forty-seven (59%) patients underwent ERCP with plastic stent placement (with or
without sphincterotomy) and 33 patients (41%) underwent sphincterotomy alone. Complete resolution was obtained in 94%
of the stent group vs. 58% of the sphincterotomy group (p< 0.01). There was no difference in three-month survival among
both groups. Percutaneous transhepatic therapy and surgery were required in 4% and 6% in the stent group vs. 12% and
42% in the sphincterotomy group, respectively (p¼ 0.22 and p< 0.001). The only predictive factor of bile leak resolution was
stent placement.
Conclusion: ERCP with plastic stent placement is highly successful and more effective than sphincterotomy alone for post-LT
bile leak treatment. These results indicate that ERCP and plastic stent placement should be considered the standard of care
for the treatment of bile leaks in LT.
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Introduction
Biliary adverse events constitute an important cause of
morbidity and mortality in patients after liver trans-
plantation (LT). Among the different types of biliary
adverse events after LT, bile leak is the second most
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frequent with an incidence of 2% to 25%.1–7 Bile leaks
are classified as anastomotic, T-tube-related, cystic
duct-related or, in the case of living donor liver
transplants (LDLT), cut-surface-related.6 Common
risk factors for the development of bile leaks are related
to surgical technique, hepatic artery thrombosis, LT
from donors after cardiac death, ABO mismatch, pro-
longed warm and cold ischemia times, and T-tube use.8
The standard of care for the treatment of bile leaks
after LT is not well established. Patients with a peri-
T-tube leak can sometimes be managed conservatively
by keeping the T-tube drainage open for a prolonged
period of time.9 Endoscopic retrograde cholangiopan-
creatography (ERCP) is also very effective and high-
resolution rates are near 90%.1–4,6–8 A variety of
ERCP techniques have been described for managing
leaks, including: nasobiliary drainage,10–13 sphincterot-
omy alone,14–17 plastic biliary stent placement with or
without out sphincterotomy,3,4,6,7,18–24 and placement
of fully covered self-expandable metallic stents
(FCSEMS).25–27 Regardless of method used, the sug-
gested mechanism of healing relates to the equalization
of pressures in the bile duct and duodenum, which
allows antegrade bile flow into the duodenum.8,10
Nevertheless, the optimal endoscopic approach has
not yet been established and to date there are very
few studies that compare the different endoscopic treat-
ment options. In addition, there are no data that define
factors predictive of endoscopic success in patients with
post-LT bile leaks. The aim of this analysis was to
evaluate data from two large institutions to determine
the role of ERCP in the treatment of bile leaks follow-
ing LT.
Materials and methods
This study was approved by the Ethical and
Institutional Review Board at the Hospital Clinic of
Barcelona (Barcelona, Spain) and Mayo Clinic
(Rochester, MN, USA). The protocol, Evaluation of
Endoscopic Therapy of Bile Leaks after Liver
Transplantation, was approved at both institutions in
May and August 2015. The study protocol conforms to
the ethical guidelines of the 1975 Declaration of
Helsinki as reflected in a prior approval by the institu-
tions’ human research committee. Informed consent of
the procedures was obtained from all patients included
in the study. LT recipients with clinical or radiologic
suspicion of a bile leak referred for ERCP were
included. We reviewed all ERCPs in patients following
LT at Mayo Clinic from July 2000 to June 2013 and at
Hospital Clinic from January 2003 through January
2015. Mayo Clinic performs between 100 and 120
LTs and approximately 2000 ERCPs yearly. Hospital
Clinic performs between 80 and 90 LTs and
approximately 450 ERCPs yearly. Data were col-
lected and entered after each case. The electronic med-
ical records and endoscopy database of both
institutions were accessed to abstract demographic,
clinical, surgical, and endoscopic data. All procedures
were performed with sedation, with levels from moder-
ate to general anesthesia. All patients received
intravenous broad-spectrum prophylactic antibiotics.
Administration of pharmacologic agents and pancre-
atic stent placement for prevention of post-ERCP pan-
creatitis were not routinely performed.
ERCP was performed using standard techniques.
After cannulation, cholangiography was performed to
confirm the leak. If necessary, an occlusion cholangio-
gram using a balloon catheter was performed to deter-
mine the leak site. After confirmation of the bile leak,
endoscopic intervention (complete sphincterotomy or
stent with or without complete sphincterotomy) was
performed at the proceduralist’s discretion. Biliary
stents were placed across the site of the bile leak,
when technically feasible; in some cases patients were
treated with biliary sphincterotomy alone.
Definitions
Bile leaks were diagnosed based on the following
criteria: (1) clinical symptoms (i.e. abdominal pain,
ascites, fever and/or jaundice); (2) the presence of a
new fluid collection consistent with a leak on cross-sec-
tional imaging; (3) increasing or persistent bilious
output from an intra-abdominal drain; (4) extravasa-
tion of contrast seen on T-tube cholangiography.
Intrahepatic leaks were defined as extravasation of
contrast due to bile duct rupture and extravasation of
bile into the hepatic parenchyma. Patients with a
peri-T-tube leak were referred for an ERCP only if
the condition persisted after leaving the T-tube to
open drainage. We only included patients with a sus-
pected bile leak confirmed by ERCP.
We defined resolution of the bile leak as the cessa-
tion of symptoms and drain output, and/or the absence
of contrast extravasation on ERCP performed eight
weeks after the initial ERCP, with a maximum of two
more ERCP treatments. In contrast to postcholecys-
tectomy leaks, where the stent is usually removed in
four weeks, in post-LT leaks it is preferred the stent
be left in place for approximately eight weeks because
of potential problems with delayed healing that may
occur because of immunosuppression.6 If initial reso-
lution was not achieved after the placement of one bil-
iary stent, a posterior ERCP was performed using a
larger diameter biliary stent or by placement of an add-
itional biliary stent. FCSEMS were not placed in any
patient. Those patients with persistent leaks were
referred for surgery or percutaneous transhepatic
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biliary drainage (PTBD) and were categorized as fail-
ures. Definitions of individual adverse events and their
severity after ERCP (i.e. pancreatitis, cholangitis, hem-
orrhage, perforation) were defined by criteria as estab-
lished by Cotton et al.28,29 Mild events were considered
when hospitalization was prolonged by two to three
days, moderate by 4–10 days, and severe by more
than 10 days.
Statistical analysis
Patient demographics, clinical and procedure data and
outcomes were analyzed. 2 or Fisher exact test were
used for categorical variables and the Student t-test for
continuous variables. Univariate analysis was con-
ducted to explore the relationships between the
patients’ characteristics, the type of transplantation,
the presence of a T-tube, immunosuppression therapy,
the type of leak, the location of the leak, the presence of
a stricture, resolution of the bile leak, the time of reso-
lution and the need for percutaneous transhepatic chol-
angiography (PTC) or surgery. Independent factors
associated with resolution of bile leak were studied
using a stepwise multivariate logistic regression model
that used initial inclusion criteria with a significance of
p 0.05, using SPSS statistical packages (version 20.0;
SPSS Inc, Chicago, IL). For this purpose, patients with
a resolved bile leak (resolution group) were compared
with those who presented with persistent bile leak after
follow-up (persistent leak group), as defined previously.
A p 0.05 was considered statistically significant.
Results
A total of 80 patients were included, 45 at Hospital
Clinic and 35 at the Mayo Clinic (mean age 55 years,
73% male). The baseline characteristics of patients are
shown in Table 1. Overall, 75% were recipients of a
cadaveric liver and 24% were living donor recipients.
Two-thirds of the patients had a T-tube after LT. The
incidence of known risk factors for bile leak was low:
hepatic artery thrombosis (9%), donors after cardiac
death (5%) and ABO blood group mismatch (1%).
Endoscopic findings are shown in Table 2. The loca-
tion of bile leaks was as follows: biliary anastomosis
(45%), T-tube (34%), intrahepatic (10%), cystic duct
remnant (9%), cut surface (2%). A concomitant anas-
tomotic biliary stricture was identified in 28% of
patients (Figure 1). The median time from LT to
ERCP was 32.25 (16–73.5) days. Biliary stent place-
ment was performed in 47 patients, 41 with sphincter-
otomy and six without sphincterotomy. The median
number of biliary stents placed per case was one. All
were plastic stents and the majority (31/47) were 10F
stents. Thirty-three patients (41%) underwent biliary
sphincterotomy alone (30 at Hospital Clinic and three
at Mayo Clinic-Rochester). The mean number of
ERCPs performed per patient was 1.8. The majority
of patients (60, 75%) required only one ERCP proced-
ure for bile leak resolution and 19 (23.8%) required two
ERCP procedures. One patient with a non-anastomotic
bile leak required three ERCPs. There were 12 cases of
a failed attempt to place a biliary stent. Of these 12
Table 1. Patient baseline characteristics.
PATIENT CHARACTERISTICS n (%)
Gender (M/F) 58/22 (72.5%/22.5%)
Age (years) 54.7 10.3
Indication/etiology of LT
HCV 33 (41.3%)
Alcohol 14 (17.5%)
HCC 23 (28.8)
Others 10 (12.5%)
Type of LT
DDLT 60 (75%)
LDLT 19 (24%)
Split 1 (1%)
T-tube 60 (75%)
Risk factors for bile leakage
Hepatic artery thrombosis. 7 (9%)
Donor after cardiac death 4 (5%)
ABO mismatch 1 (1%)
Immunosuppression therapy
Tacrolimus 61 (76.3%)
Cyclosporine 9 (11.3%)
Prednisone 75 (93.8%)
Mycophenolic acid 48 (60%)
Sirolimus 5 (6.3%)
M: male; F: female; LT: liver transplant; HCV: hepatitis C virus; HCC: hepa-
tocellular carcinoma; DDLT: deceased donor liver transplant; LDLT: living
donor liver transplant.
Table 2. Endoscopic findings.
TYPE OF LEAK
Anastomotic leak 36 (45%)
Peri-T-tube leak 27 (34%)
Spontaneous 13 (16%)
After removal of T-tube 14 (17%)
Intrahepatic 8 (10%)
Cystic 7 (9%)
Cut surface leak 2 (2%)
Anastomotic stricture 22 (28%)
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cases in two the stent could not be placed because of a
large disruption and inability to pass the guidewire into
a proximal bile duct. In the remaining 10 cases the stent
was not placed because of concomitant stricture that
could not be traversed with a guidewire in order to
place a stent.
Factors associated with bile leak resolution
were analyzed with univariate and multivariate ana-
lysis as shown in Table 3 and 4. The only predictive
factor of bile leak resolution on the multivariate ana-
lysis was ERCP with stent placement (odds ratio, 8.36;
95% confidence interval, 1.79–39.03; p¼ 0.007)
Figure 1. Characteristic findings of a bile leak with an anastomotic stricture. (a) Bile leak and anastomotic stricture. (b) Stent placement
across the bile leak site.
Table 3. Factors associated with bile leak resolution.
Resolution group
(n¼ 63)
Persistent leak group
(n¼ 17) p value
Univariate analysis
Sex (M/F) 45/18 13/4 NS
Arterial thrombosis rate (n (%)) 5 (7.9%) 2 (11.8%) NS
ABO mismatch rate (n (%)) 0 0 1 (5.9%) NS
LDLT (n (%)) 3 (4.8%) 1 (5.9) NS
HCV (n (%)) 27 (42.9%) 6 (35.3%) NS
HCC (n (%)) 19 (30.2%) 4 (23.5) NS
Use of T-tube (n (%)) 48 (76.2%) 12 (70.6%) NS
Tacrolimus (n (%)) 51 (81%) 10 (58.8%) 0.06
Cyclosporine (n (%)) 5 (7.9%) 4 (23.5%) 0.09
Sirolimus (n (%)) 3 (4.8%) 2 (11.8%) NS
Mycophenolic acid (n (%)) 43 (68.3%) 5 (29.4%) .005
Corticosteroids (n (%)) 59 (93.7%) 16 (94.1%) NS
Anastomotic location (n (%)) 26 (41.3%) 10 (58.8%) NS
Anastomotic stricture (n (%)) 15 (23.8%) 7 (41.2%) NS
Time of LT> 3 months (n (%)) 12 (19%) 2 (11.8%) NS
Stent placement (n (%)) 44 (69.8%) 3 (17.6%) <0.001
M: male; F: female; LDLT: living donor liver transplant; HCV: hepatitis C virus; HCC: hepatocellular carcinoma; LT: liver transplant.
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(Table 4). ERCP and patient-related outcomes are out-
lined in Table 5. Overall resolution of bile leaks with
ERCP therapy was observed in 63 out of 80 (79%)
patients. The resolution rate per location was: anasto-
motic leak (72.2%), T-tube-related leak (88.9%), intra-
hepatic (87.5%), cystic remnant leak (71.4%) and cut
surface leak (50%), (Supplementary table). Successful
resolution of bile leak occurred in 93.6% of patients in
the biliary stent group and 57.6% of the sphincterot-
omy group (p< 0.01). There was no difference in three-
month survival between groups.
Failure of ERCP therapy occurred in 14 (42.4%)
patients in the sphincterotomy group and three patients
in the stent group (6.4%). In these cases, two patients
underwent PTBD, two patients underwent PTBD plus
surgery and 11 underwent surgery without prior PTBD.
In two patients no further therapy was performed.
Eight (10%) patients developed post-ERCP adverse
events: mild acute pancreatitis (n¼ 5), mild bleeding
(n¼ 2), and mild pancreatitis with concomitant cholan-
gitis (n¼ 1). All adverse events were managed
conservatively.
Discussion
We sought to analyze ERCP-guided treatment
approaches for patients with bile leaks after LT. The
results of this analysis from two large academic medical
centers indicate that ERCP therapy with placement of a
biliary plastic stent (with or without biliary sphincter-
otomy) is highly successful and significantly more
effective than biliary sphincterotomy alone.
Bile leaks are the second most common biliary
adverse event following LT and constitute significant
morbidity for LT recipients. In addition, bile leaks
are considered an independent risk factor for the
development of early or late anastomotic biliary stric-
tures and thus require a prompt, safe and highly effect-
ive therapy.8,30–32 In this analysis 75% of patients had
T-tube placement. T-tubes have been routinely placed
as a prophylactic measure for anastomotic stricture
development. However, the results of several compara-
tive studies, systematic reviews and meta-analyses
suggest no major differences in the incidence of biliary
complications, and the current trend has favored more
the abandonment of the use of T-tubes after LT in most
centers.33 Most bile leaks can be resolved non-opera-
tively with early intervention. The most widely accepted
treatment approach in patients with a duct-to-duct bil-
iary anastomosis is early ERCP-guided endoscopic
therapy.1–4,6–8 ERCP-guided endoscopic therapy of
bile leaks can be performed with a combination of bil-
iary sphincterotomy and plastic stent placement or with
sphincterotomy alone. Some authors propose the use of
biliary sphincterotomy alone as it is easy to perform
and patients do not require a subsequent ERCP for
stent removal; however, most of the available data sup-
porting this practice stem from patients with bile leaks
following cholecystectomy.14,16,34,35 In the case of bile
leaks after LT, available data regarding the use of bil-
iary sphincterotomy alone for bile leaks are scant and
limited to large series of patients treated for an array of
biliary adverse events after LT.14–17 The success rate of
this approach in LT is poorly understood as no rando-
mized controlled trials have directly compared this
strategy to sphincterotomy plus biliary plastic stent
placement. We believe plastic stent placement for bile
leaks after LT has the advantage of preferentially
diverting bile flow to the duodenum through the elim-
ination of the transpapillary pressure gradient, and per-
haps could be the reason why stent placement was
responsible for better outcomes when compared to
sphincterotomy alone. In this analysis, a center effect
was clear as most of the cases with sphincterotomy
alone were performed at Hospital Clinic. The reso-
lution rate at Hospital Clinic was 69% vs. 91% at
Mayo Clinic (p¼ 0.014). That said, the center effect is
driven only by the fact that sphincterotomy alone was
Table 4. Multivariate logistic regression model assessing factors
associated with resolution of bile leaks after liver transplantation.
Coefficient
Standard
error OR (CI 95%)
p
value
Tacrolimus 1.028 0.920 2.79 (0.46–16.95) 0.264
Cyclosporine 0.504 1.153 1.65 (0.17–15.86) 0.662
Mycophenolic
acid
0.925 0.665 2.52 (0.68–9.28) 0.167
Stent placement 2.124 0.786 8.36 (1.79–39.03) 0.007
OR: odds ratio; CI: confidence interval.
Table 5. ERCP and patient-related outcomes.
Stent group
(n¼ 47)
Sphincterotomy
alone group
(n¼ 33) p value
RESOLUTION
(n (%))
44 (93.6%) 19 (57.6%) <0.001
NEED FOR PTBD
(n (%))
2 (4.3%) 4 (12.1%) NS
NEED FOR SURGERY
(n (%))
3 (6.4%) 14 (42.4%) <0.001
SURVIVAL (3 months)
(n (%))
44 (93.6%) 30 (90.9%) NS
ERCP: endoscopic retrograde cholangiopancreatography; PTBD: percutan-
eous transhepatic biliary drainage.
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performed mostly at Hospital Clinic. We did not find
other differences in relation to the type of surgical
technique or risk factors for bile leaks. Therefore, we
believe this approach should be preferred over
sphincterotomy alone as it appears to increase ante-
grade bile flow, subsequently promoting healing at the
leakage site.
Several studies have reported outcomes of
endoscopic therapy for bile leaks after LT, but to our
knowledge this is the only study that has analyzed the
effectiveness of biliary sphincterotomy alone vs. plastic
stent placement with or without sphincterotomy in two
high-volume centers. Among the factors associated
with the resolution of the bile leak after LT, multivari-
ate analysis identified ERCP with stent placement as
the only factor predictive of bile leak resolution (odds
ratio, 8.36; 95% confidence interval, 1.79–39.03;
p¼ 0.007). Simmons et al. investigated whether sphinc-
terotomy should routinely be performed along with
stent placement when managing bile leaks.36 In this
study, the investigators identified a higher rate of
post-ERCP pancreatitis after placement of large-bore
biliary stents when sphincterotomy was not performed
suggesting that sphincterotomy might be protective of
post-ERCP pancreatitis when 10Fr stents are placed,
and that otherwise sphincterotomy alone did not
confer additional benefit for the treatment of bile
leak.36 Our findings confirm the results of a recent mul-
ticenter study of patients with post-cholecystectomy
bile leaks.37 In this study, 162 out of 178 patients
(91%) had complete resolution of their bile leak after
therapy with biliary sphincterotomy and biliary plastic
stent placement. Although there are centers that per-
form sphincterotomy alone for bile leaks, a recent study
in patients with bile leaks after liver resection showed
that endoscopic sphincterotomy without stent insertion
(p¼ 0.002) was significantly associated with failure of
endoscopic therapy.20
Though controversial, some authors recommend dif-
ferent endoscopic techniques based on the size of the
bile leak, suggesting that small leaks may be managed
with sphincterotomy alone.14,24 In contrast, our find-
ings suggest that placement of a biliary stent with or
without sphincterotomy for the treatment of bile leaks
results in a high rate of resolution compared to sphinc-
terotomy alone regardless of the bile leak location.
Aside from these two approaches (sphincterotomy
alone and sphincterotomy with plastic stent placement),
some authors also advocate the use of FCSEMS for
patients with bile leaks (mainly post-cholecystectomy
leaks) given the high resolution rates (93%–95%) in
early studies.26,27,38,39 In our clinical experience
FCSEMS are useful in some LT recipients with large
or refractory bile leaks, though FCSEMS were not
placed during the present study. While FCSEMS may
be effective for bile leaks, some stents carry a risk of
new stricture formation in LT recipients, thus more
information is needed in these patients.25
A number of studies indicate that the location of the
bile leak is a key factor predicting ERCP-directed treat-
ment success. Pfau et al.4 described a significantly lower
success rate of endoscopic treatment of anastomotic
leaks (42.9%) compared with T-tube-related leaks
(95.2%). In a recent study by Tewani et al.21 that
included a variety of post-surgical bile leaks (i.e. post-
cholecystectomy, hepatobiliary surgery, LT), post-
cholecystectomy bile leak was identified as a predictive
factor for ERCP therapy success compared with leaks
after hepatobiliary surgery. Interestingly, in a subgroup
analysis 90% of post-LT bile leaks were successfully
treated after a single ERCP with stent placement.21
Finally, one group proposed classifying post-cholecys-
tectomy leaks into low-grade and high-grade. Leaks
visualized at the intrahepatic biliary branches were con-
sidered low grade, while those seen below the intrahe-
patics were considered high grade. Low-grade leaks
managed with sphincterotomy alone had a high success
and high-grade leaks managed with stents and sphinc-
terotomy also had very high success.24 Our study
focuses only on LT recipients and we found that the
majority of bile leaks occurred at the anastomotic site
(45%) and peri-T-tube site (34%); however, leak site
was not a predictor of endoscopic success.
There are inherent limitations in our study.
Although this analysis was carried out at two high-
volume centers, it is a retrospective analysis including
a relatively low number of patients. The study is a
descriptive analysis of the ERCP practices at two cen-
ters and not a true comparative study of two endo-
scopic approaches. Also, we were unable to record
the bile duct mismatch and size of the bile leaks.
Finally, the management strategy for patients in
which the first ERCP failed to resolve the bile leak
was at the discretion of each proceduralist.
In summary, our study indicates that ERCP with
biliary plastic stent placement with or without sphinc-
terotomy is a highly effective therapy for bile leaks after
LT and should be considered the standard of care in
this clinical situation.
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